Inhibition of ANXA2 Activity Attenuates Epileptic Susceptibility and GluA1 Phosphorylation

Overview

Journal CNS Neurosci Ther

Specialties Neurology
Pharmacology

Date 2023 Jun 11

PMID 37302990

Authors

Limin Ma

Qingyuan Wu

Jinxian Yuan

You Wang

Peng Zhang

Qiankun Liu

Dandan Tan

Minxue Liang

Yangmei Chen

Affiliations

Soon will be listed here.

Abstract

Introduction: Annexin A2 (ANXA2) participates in the pathology of a variety of diseases. Nevertheless, the impact of ANXA2 on epilepsy remains to be clarified.

Aims: Hence, the study aimed at investigating the underlying role of ANXA2 in epilepsy through behavioral, electrophysiological, and pathological analyses.

Results: It was found that ANXA2 was markedly upregulated in the cortical tissues of temporal lobe epilepsy patients (TLE), kainic acid (KA)-induced epilepsy mice, and in a seizure-like model in vitro. ANXA2 silencing in mice suppressed first seizure latency, number of seizures, and seizure duration in behavioral analysis. In addition, abnormal brain discharges were less frequent and shorter in the hippocampal local field potential (LFP) record. Furthermore, the results showed that the frequency of miniature excitatory postsynaptic currents was decreased in ANXA2 knockdown mice, indicating that the excitatory synaptic transmission is reduced. Co-immunoprecipitation (COIP) experiments demonstrated that ANXA2 interacted with the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) subunit GluA1. Moreover, ANXA2 knockdown decreased GluA1 expression on the cell surface and its phosphorylation onserine 831 and serine 845, related to the decreased phosphorylation levels mediated by protein kinases A and C (PKA and PKC).

Conclusions: This study covers a previously unknown and key function of ANXA2 in epilepsy. These findings indicate that ANXA2 can regulate excitatory synaptic activity mediated by AMPAR subunit GluA1 to improve seizure activity, which can provide novel insights for the treatment and prevention of epilepsy.

Citing Articles

GLS2 reduces the occurrence of epilepsy by affecting mitophagy function in mouse hippocampal neurons.

Gao Y, Ma L, Yuan J, Huang Y, Ban Y, Zhang P CNS Neurosci Ther. 2024; 30(10):e70036.

PMID: 39404053 PMC: 11474837. DOI: 10.1111/cns.70036.

The role of annexins in central nervous system development and disease.

White 2nd Z, Nair S, Bredel M J Mol Med (Berl). 2024; 102(6):751-760.

PMID: 38639785 PMC: 11106189. DOI: 10.1007/s00109-024-02443-7.

Inhibition of ANXA2 activity attenuates epileptic susceptibility and GluA1 phosphorylation.

Ma L, Wu Q, Yuan J, Wang Y, Zhang P, Liu Q CNS Neurosci Ther. 2023; 29(11):3644-3656.

PMID: 37302990 PMC: 10580353. DOI: 10.1111/cns.14295.

References

Hu D, Guo Y, Wu M, Ma Y, Jing W . GDAP2 Overexpression Affects the Development of Neurons and Dysregulates Neuronal Excitatory Synaptic Transmission. Neuroscience. 2022; 488:32-43. DOI: 10.1016/j.neuroscience.2022.02.005. View

Hirai M, Fukushima H, Hiraki K . An event-related potentials study of biological motion perception in humans. Neurosci Lett. 2003; 344(1):41-4. DOI: 10.1016/s0304-3940(03)00413-0. View

Ma L, Li R, Huang H, Yuan J, Ou S, Xu T . Up-regulated BAFF and BAFF receptor expression in patients with intractable temporal lobe epilepsy and a pilocarpine-induced epilepsy rat model. Seizure. 2017; 48:79-88. DOI: 10.1016/j.seizure.2017.03.016. View

Kim J, Choi H, Song H, Kang T . Perampanel Affects Up-Stream Regulatory Signaling Pathways of GluA1 Phosphorylation in Normal and Epileptic Rats. Front Cell Neurosci. 2019; 13:80. PMC: 6405474. DOI: 10.3389/fncel.2019.00080. View

Wang Y, Yuan J, Yu X, Liu X, Tan C, Chen Y . Vezatin regulates seizures by controlling AMPAR-mediated synaptic activity. Cell Death Dis. 2021; 12(10):936. PMC: 8511046. DOI: 10.1038/s41419-021-04233-2. View

Hosokawa T, Mitsushima D, Kaneko R, Hayashi Y . Stoichiometry and phosphoisotypes of hippocampal AMPA-type glutamate receptor phosphorylation. Neuron. 2014; 85(1):60-67. PMC: 4289098. DOI: 10.1016/j.neuron.2014.11.026. View

Racine R . Modification of seizure activity by electrical stimulation. I. After-discharge threshold. Electroencephalogr Clin Neurophysiol. 1972; 32(3):269-79. DOI: 10.1016/0013-4694(72)90176-9. View

Rakhade S, Zhou C, Aujla P, Fishman R, Sucher N, Jensen F . Early alterations of AMPA receptors mediate synaptic potentiation induced by neonatal seizures. J Neurosci. 2008; 28(32):7979-90. PMC: 2679369. DOI: 10.1523/JNEUROSCI.1734-08.2008. View

Wang C, Lin C . Annexin A2: its molecular regulation and cellular expression in cancer development. Dis Markers. 2014; 2014:308976. PMC: 3925611. DOI: 10.1155/2014/308976. View

10.

Miyazaki T, Nakajima W, Hatano M, Shibata Y, Kuroki Y, Arisawa T . Visualization of AMPA receptors in living human brain with positron emission tomography. Nat Med. 2020; 26(2):281-288. DOI: 10.1038/s41591-019-0723-9. View

11.

Yang Y, He M, Tian X, Guo Y, Liu F, Li Y . Transgenic overexpression of furin increases epileptic susceptibility. Cell Death Dis. 2018; 9(11):1058. PMC: 6193048. DOI: 10.1038/s41419-018-1076-x. View

12.

Selvakumar B, Jenkins M, Hussain N, Huganir R, Traynelis S, Snyder S . S-nitrosylation of AMPA receptor GluA1 regulates phosphorylation, single-channel conductance, and endocytosis. Proc Natl Acad Sci U S A. 2013; 110(3):1077-82. PMC: 3549090. DOI: 10.1073/pnas.1221295110. View

13.

Rakhade S, Fitzgerald E, Klein P, Zhou C, Sun H, Huganir R . Glutamate receptor 1 phosphorylation at serine 831 and 845 modulates seizure susceptibility and hippocampal hyperexcitability after early life seizures. J Neurosci. 2012; 32(49):17800-12. PMC: 3574823. DOI: 10.1523/JNEUROSCI.6121-11.2012. View

14.

Coultrap S, Freund R, OLeary H, Sanderson J, Roche K, DellAcqua M . Autonomous CaMKII mediates both LTP and LTD using a mechanism for differential substrate site selection. Cell Rep. 2014; 6(3):431-7. PMC: 3930569. DOI: 10.1016/j.celrep.2014.01.005. View

15.

Liu Y, Wang Y, Yang J, Xu T, Tan C, Zhang P . G-alpha interacting protein interacting protein, C terminus 1 regulates epileptogenesis by increasing the expression of metabotropic glutamate receptor 7. CNS Neurosci Ther. 2021; 28(1):126-138. PMC: 8673704. DOI: 10.1111/cns.13746. View

16.

Segal M . Dendritic spines, synaptic plasticity and neuronal survival: activity shapes dendritic spines to enhance neuronal viability. Eur J Neurosci. 2010; 31(12):2178-84. DOI: 10.1111/j.1460-9568.2010.07270.x. View

17.

Riquelme J, Wellmann M, Sotomayor-Zarate R, Bonansco C . Gliotransmission: A Novel Target for the Development of Antiseizure Drugs. Neuroscientist. 2020; 26(4):293-309. DOI: 10.1177/1073858420901474. View

18.

Weiss R, Bitton A, Ben Shimon M, Elhaik Goldman S, Nahary L, Cooper I . Annexin A2, autoimmunity, anxiety and depression. J Autoimmun. 2016; 73:92-9. DOI: 10.1016/j.jaut.2016.06.011. View

19.

Diering G, Heo S, Hussain N, Liu B, Huganir R . Extensive phosphorylation of AMPA receptors in neurons. Proc Natl Acad Sci U S A. 2016; 113(33):E4920-7. PMC: 4995952. DOI: 10.1073/pnas.1610631113. View

20.

Moshe S, Perucca E, Ryvlin P, Tomson T . Epilepsy: new advances. Lancet. 2014; 385(9971):884-98. DOI: 10.1016/S0140-6736(14)60456-6. View